Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Dow
Moodys
Express Scripts
Medtronic

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Sulfur hexafluoride lipid-type a microspheres - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for sulfur hexafluoride lipid-type a microspheres and what is the scope of freedom to operate?

Sulfur hexafluoride lipid-type a microspheres is the generic ingredient in one branded drug marketed by Bracco and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Sulfur hexafluoride lipid-type a microspheres has one hundred and forty-one patent family members in twenty-eight countries.

There are two drug master file entries for sulfur hexafluoride lipid-type a microspheres. Two suppliers are listed for this compound.

Summary for sulfur hexafluoride lipid-type a microspheres
Recent Clinical Trials for sulfur hexafluoride lipid-type a microspheres

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Children's Mercy Hospital Kansas CityPhase 2
National Cancer Institute (NCI)Early Phase 1
M.D. Anderson Cancer CenterEarly Phase 1

See all sulfur hexafluoride lipid-type a microspheres clinical trials

Synonyms for sulfur hexafluoride lipid-type a microspheres
[SF6]
2551-62-4
29267-82-1
36575-03-8
59109-69-2
A817889
AC1L29UB
ACMC-1CQA3
AKOS015960568
BRI
CHEBI:30496
CHEMBL1796998
CTK1A2580
D05962
DB11104
DTXSID8029656
EC 219-854-2
EINECS 219-854-2
Elagas
Elegas
Esaflon
hexafluoridosulfur
hexafluoro-|E6-sulfane
hexafluoro-$l^{6}-sulfane
hexafluoro-l6-sulfane
Hexafluorosulfur
Hexafluorure de soufre
Hexafluorure de soufre [French]
hexakis(fluoranyl)-$l^{6}-sulfane
HSDB 825
LS-148165
Lumason
MolPort-001-776-565
OC-6-11
R 7146
SBB086453
SF6
SF6 Microbubbles
SFZCNBIFKDRMGX-UHFFFAOYSA-N
SonoVue
SonoVue (for the microbubble formulation)
Sonovue (TN)
Stabilized sulfur hexafluoride microbubbles
Sulfur fluoride (SF6)
Sulfur fluoride (SF6), (OC-6-11)-
Sulfur fluoride, (OC-6-11)-
SULFUR HEXAFLUORIDE
Sulfur hexafluoride (USAN)
Sulfur hexafluoride [UN1080] [Nonflammable gas]
Sulfur hexafluoride [UN1080] [Nonflammable gas]
Sulfur hexafluoride [USAN]
Sulfur hexafluoride lipid microsphere
Sulfur hexafluoride, >=99.75%
sulfur(6+) fluoride
sulfur(VI) fluoride
Sulfuric fluoride
Sulphur hexafluoride
TC-165101
UN 1080
UN1080
UNII-WS7LR3I1D6
WS7LR3I1D6
ZINC245224194

US Patents and Regulatory Information for sulfur hexafluoride lipid-type a microspheres

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco LUMASON sulfur hexafluoride lipid-type a microspheres FOR SUSPENSION;INTRAVENOUS 203684-001 Oct 15, 2014 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
Bracco LUMASON sulfur hexafluoride lipid-type a microspheres FOR SUSPENSION;INTRAVENOUS 203684-001 Oct 15, 2014 RX Yes Yes   Start Trial   Start Trial   Start Trial
Bracco LUMASON sulfur hexafluoride lipid-type a microspheres FOR SUSPENSION;INTRAVENOUS 203684-001 Oct 15, 2014 RX Yes Yes   Start Trial   Start Trial   Start Trial
Bracco LUMASON sulfur hexafluoride lipid-type a microspheres FOR SUSPENSION;INTRAVENOUS 203684-001 Oct 15, 2014 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Bracco LUMASON sulfur hexafluoride lipid-type a microspheres FOR SUSPENSION;INTRAVENOUS 203684-001 Oct 15, 2014 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Supplementary Protection Certificates for sulfur hexafluoride lipid-type a microspheres

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1556389 16C0004 France   Start Trial PRODUCT NAME: CEFTOLOZANE,EVENTUELLEMENT SOUS LA FORME D'UN SEL PHARMACEUTIQUEMENT ACCEPTABLE,PLUS PARTICULIEREMENT UN SEL D'ACIDE SULFURIQUE; REGISTRATION NO/DATE: EU/1/15/1032 20150922
1556389 92943 Luxembourg   Start Trial PRODUCT NAME: CEFTOLOZANE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE, EN PARTICULIER UN SEL D'ACIDE SULFURIQUE (ZERBAXA); FIRST REGISTRATION: 20150922
0619743 SPC/GB01/043 United Kingdom   Start Trial PRODUCT NAME: SULPHUR HEXAFLUORIDE; REGISTERED: UK EU/1/01/177/001 20010326; UK EU/1/01/177/002 20010326
0619743 01C0036 France   Start Trial PRODUCT NAME: SULPHUR HEXAFLUORIDE; REGISTRATION NO/DATE: EU/1/01/177/001 20010326
0619743 29/2001 Austria   Start Trial PRODUCT NAME: SCHWEFELHEXAFLUORID ENTHALTENDE, DURCH PHOSPHORLIPID STABILISIERTE MIKROBLAESCHEN; REGISTRATION NO/DATE: EU/1/01/177/001, EU/1/01/177/002 20010326
1556389 2015/074 Ireland   Start Trial PRODUCT NAME: CEFTOLOZANE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR A SULFURIC ACID SALT; REGISTRATION NO/DATE: EU/1/15/1032/001 20150918
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
McKinsey
Express Scripts
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.